EPSTEIN-BARR_VIRUS

作品数：211被引量：797H指数：14
导出分析报告
相关作者：罗兵翁新宪顾焕华邓锡云曹亚更多>>
相关机构：青岛大学湖南医科大学福建省肿瘤医院昆明医科大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划北京市自然科学基金国家高技术研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Cancer Communicationsx
共 条 记 录，以下是1-7
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture
《Cancer Communications》2024年第4期491-494,共4页Chu-Xia Deng 
Macao Science and Technology Development Fund,Grant/Award Number:0009/2022/AKP。
Immune checkpoint inhibitor(ICI)therapy has sig-nificantly revolutionized cancer treatment across vari-ous malignancies,offering distinct and enduring clin-ical advantages[1].Gastric cancer(GC)represents a widespread ...
关键词：GASTRIC cancer IMMUNE 
Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma被引量：11
《Cancer Communications》2020年第11期564-585,共22页Rong Tan Sean Kean Ann Phua Yoke Lim Soong Lynette Lin Ean Oon Kian Sing Chan Sasidharan Swarnalatha Lucky Jamie Mong Min Han Tan Chwee Ming Lim 
Nasopharyngeal carcinoma(NPC)is a malignant epithelial tumor ubiquitously associated with the Epstein-Barr virus(EBV),which is highly prevalent in South China,Southeast Asia,and North Africa.Despite being a highly rad...
关键词：circulating tumor cells EBV DNA Epstein-Barr virus microRNA nasopharyngeal carcinoma prognosis screening SEROLOGY surveillance 
A novel Epstein-Barr virus subtype associated with nasopharyngeal carcinoma found in South China
《Cancer Communications》2020年第1期60-62,共3页Lawrence S.Young 
Nasopharyngeal carcinoma(NPC)is a unique malignancy closely associated with Epstein-Barr virus(EBV)infection and with a restricted geographical distribution[1].According to a recent World Health Organization(WHO)repor...
关键词：NASOPHARYNGEAL NASOPHARYNGEAL CASES 
The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma:A propensity score matching study被引量：5
《Cancer Communications》2020年第1期32-42,共11页Xue-Song Sun Sai-Lan Liu Yu-Jing Liang Qiu-Yan Chen Xiao-Yun Li Lin-Quan Tang Hai-Qiang Mai 
National Key R&D Program of China,Grant/Award Numbers:2016YFC0902003,2017YFC1309003,2017YFC0908500;National Natural Science Foundation of China,Grant/Award Numbers:81425018,81672868,81602371;Sun Yat-sen University Clinical Research 5010 Program,Grant/Award Numbers:201707020039,2014A020212103,16zxyc02;Sci-Tech Project Foundation of Guangzhou City,Grant/Award Number:201707020039;National Key Basic Research Program of China,Grant/Award Number:2013CB910304;Special Support Plan of Guangdong Province,Grant/Award Number:2014TX01R145;Sci-Tech Project Foundation of Guangdong Province,Grant/Award Number:2014A020212103;Health&Medical Collaborative Innovation Project of Guangzhou City,Grant/Award Number:201400000001;National Science&Technology Pillar Program during the Twelfth Five-year Plan Period,Grant/Award Number:2014BAI09B10;PhD Start-up Fund of Natural Science Foundation of Guangdong Province,China,Grant/Award Number:2016A030310221;cultivation foundation for the junior teachers in Sun Yat-sen University,Grant/Award Number:16ykpy28;foundation for major projects and new cross subjects in Sun Yat-sen University,Grant/Award Number:16ykjc38。
Background:Capecitabine was previously used as a second-line or salvage therapy for metastatic nasopharyngeal carcinoma(NPC)and has shown satisfactory curative effect as maintenance therapy in other metastatic cancers...
关键词：CAPECITABINE de novo Epstein-Barr virus LOCOREGIONAL maintenance therapy nasopharyngeal carcinoma propensity score matching RADIOTHERAPY survival 
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients:a retrospective study被引量：5
《Cancer Communications》2019年第1期135-147,共13页Sai-Lan Liu Xue-Song Sun Xiao-Yun Li Lin-Quan Tang Qiu-Yan Chen Huan-Xin Lin Yu-Jing Liang Jin-Jie Yan Chao Lin Shan-Shan Guo Li-Ting Liu Yang Li Hao-Jun Xie Qing-Nan Tang Hu Liang Ling Guo Hai-Qiang Mai 
This study was supported by grants from the National Key R&D Program of China(2016YFC0902003,2017YFC1309003,2017YFC0908500);the National Natural Science Foundation of China(No.81425018,No.81672868,No.81602371,No.81572848,No.81772877,No.81372814,No.81773103);the Sun Yat-sen University Clinical Research 5010 Program,the Sci-Tech Project Foundation of Guangzhou City(201707020039);the National Key Basic Research Program of China(No.2013CB910304);the Special Support Plan of Guangdong Province(No.2014TX01R145);the Sci-Tech Project Foundation of Guangdong Province(No.2014A020212103,No.2012B031800255,No.2014A020212528);Guangzhou Science and Technology Planning Project China(No.2014J4100181);the Health&Medical Collaborative Innovation Project of Guangzhou City(No.201400000001);the National Science&Technology Pillar Program during the Twelfth Five-year Plan Period(No.2014BAI09B10);the PhD Start-up Fund of Natural Science Foundation of Guangdong Province,China(2016A030310221);the Cultivation Foundation for Junior Teachers of Sun Yat-sen University(16ykpy28);the Fundamental Research Funds for the Central Universities
Background:Currently,the diagnosis and treatment of nasopharyngeal carcinoma(NPC)patients with residual cervical lymphadenopathy following radical radiotherapy with or without chemotherapy are challenging.We investiga...
关键词：Nasopharyngeal carcinoma Residual cervical lymphadenopathy PROGNOSIS Epstein-Barr virus Fine needle aspiration cytology SURVIVAL 
IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma被引量：7
《Cancer Communications》2018年第1期667-676,共10页Liang Wang Xi-wen Bi Yu-jia Zhu Ying-zhi He Qiu-yu Lai Zhong-jun Xia Qing-qing Cai 
the National Natural Science Foundation of China(81400159,81873450,81700196,81672686);Pearl River Nova Program of Guangzhou(201710010161);Sister Institution Net-work Fund of the MD Anderson Cancer Center(to Qingqing Cai);the Fundamental Research Funds for the Central Universities(17ykpy77).
Background:Natural killer/T-cell lymphoma(NKTCL)is a highly aggressive non-Hodgkin lymphoma often resistant to chemotherapy.Serum level of soluble IL-2 receptorα(IL-2Rα)is elevated in NKTCL patients and correlates s...
关键词：Natural killer/T-cell lymphoma Latent membrane protein 1 Epstein-Barr virus Interleukin-2 receptor alpha 
Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma被引量：2
《Cancer Communications》2018年第1期81-94,共14页Meng-Jie Yang Jie Guo Yan-Fang Ye Sui-Hong Chen Li-Xia Peng Chu-Yang Lin Ting Hu Shang-Hang Xie Chuan-Bo Xie Qi-Hong Huang Yu-Qiang Lu Qing Liu Chao-Nan Qian Su-Mei Cao 
supported by the National Key R&D Program of China(No.2016YF0902000 and No.2017YF0907100 to S.C.);the National Natural Science Foundation of China(No.81373068 to S.C.,and No.81672872,No.81272340 and No.81472386 to C.Q.);National Key Research and Development Program of China(No.2014BAI09B and No.2016YFC0902001 to S.C.);the Science and Technology Planning Project of Guangdong Province,China(No.2014B020212017,No.2014B050504004 and No.2015B050501005 to C.Q.);the Provincial Natural Science Foundation of Guangdong,China(No.2016A030311011 to C.Q.).
Background:The association of circulating inflammation markers with nasopharyngeal carcinoma(NPC)is still largely unclear.This study aimed to comprehensively explore the relationship between circulating cytokine level...
关键词：Nasopharyngeal carcinoma Prospective study Inflammatory cytokine Macrophage inflammatory protein Epstein-Barr virus 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部